A Combinatorial in Silico and Cellular Approach to Identify a New Class of Compounds That Target VEGFR2 Receptor Tyrosine Kinase Activity and Angiogenesis

British Journal of Pharmacology- United States

doi 10.1111/j.1476-5381.2011.01801.x

Full Text

Abstract

Available in

Categories

Pharmacology

Date

Authors

Publisher

Wiley

Related search

The Neuronal Receptor Tyrosine Kinase Alk Is a Target for Longevity

Aging Cell
AgingCell Biology
2020English

Specific, Irreversible Inactivation of the Epidermal Growth Factor Receptor and erbB2, by a New Class of Tyrosine Kinase Inhibitor

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1998English

Evidence That Pp42, a Major Tyrosine Kinase Target Protein, Is a Mitogen-Activated Serine/Threonine Protein Kinase.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1989English

The Ephrin Receptor Tyrosine Kinase A2 Is a Cellular Receptor for Kaposi's Sarcoma–associated Herpesvirus

Nature Medicine
BiochemistryMedicineGeneticsMolecular Biology
2012English

Tyrosine Kinase Inhibitor and Target Therapy

2013English

Receptor Tyrosine Kinase (RTK); VEGF-A

Science-Business eXchange
2014English

Ror2 Receptor Requires Tyrosine Kinase Activity to Mediate Wnt5A Signaling

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2009English

A Basic Residue C-Terminal to Tyrosine Compromises Its Viability as a Tyrosine Kinase Target

Biochemical Society Transactions
Biochemistry
1995English

Hair Depigmentation During Chemotherapy With a Class III/V Receptor Tyrosine Kinase Inhibitor

Archives of Dermatology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy